Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
As of close of business last night, SELLAS Life Sciences Group Inc’s stock clocked out at $2.08, down -5.02% from its previous closing price of $2.19. In other words, the price has decreased by -$5.02 from its previous closing price. On the day, 3.27 million shares were traded. SLS stock price reached its highest trading level at $2.17 during the session, while it also had its lowest trading level at $2.05.
Ratios:
To gain a deeper understanding of SLS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.64 and its Current Ratio is at 4.64. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on July 21, 2021, initiated with a Overweight rating and assigned the stock a target price of $18.
On April 02, 2018, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 02, 2018, with a $11 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 12 ’25 when VAN NOSTRAND ROBERT L bought 10,000 shares for $1.48 per share. The transaction valued at 14,800 led to the insider holds 20,400 shares of the business.
Wasman Jane bought 20,000 shares of SLS for $33,800 on May 30 ’25. The Director now owns 30,400 shares after completing the transaction at $1.69 per share. On May 22 ’25, another insider, Kalin Katherine Bach, who serves as the Director of the company, bought 20,000 shares for $1.80 each. As a result, the insider paid 36,000 and bolstered with 41,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SLS now has a Market Capitalization of 207537200 and an Enterprise Value of 190985696.
Stock Price History:
The Beta on a monthly basis for SLS is 2.32, which has changed by 0.82456136 over the last 52 weeks, in comparison to a change of 0.11937654 over the same period for the S&P500. Over the past 52 weeks, SLS has reached a high of $2.22, while it has fallen to a 52-week low of $0.77. The 50-Day Moving Average of the stock is 26.12%, while the 200-Day Moving Average is calculated to be 61.35%.
Shares Statistics:
It appears that SLS traded 2.60M shares on average per day over the past three months and 4550300 shares per day over the past ten days. A total of 99.78M shares are outstanding, with a floating share count of 97.67M. Insiders hold about 2.11% of the company’s shares, while institutions hold 14.33% stake in the company. Shares short for SLS as of 1749772800 were 18897977 with a Short Ratio of 7.28, compared to 1747267200 on 8756643. Therefore, it implies a Short% of Shares Outstanding of 18897977 and a Short% of Float of 19.139999.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
